Astral Systems raises £23M to tackle the global shortages of medical radioisotopes
Astral Systems, a deeptech company pioneering multi-state fusion (MSF) technology, has secured a £23 million first close investment led by Mercia Ventures. The round is supported by various investors ... Astral Fusion is developing fusion technologies for life-saving radioisotopes, clean energy, and future space exploration.
Key Takeaways
- Deeptech Astral Systems raises £23M to tackle the global shortages of medical radioisotopes Astral Fusion is developing fusion technologies for life-saving radioisotopes, clean energy, and future space exploration.
Cate Lawrence 2 hours ago Share 1 Send email Copy link Astral Systems, a deeptech company pioneering multi-state fusion (MSF) technology, has secured a £23 million first close investment led by Mercia Ventures .
- It aims to tackle the fragile supply chain and potential global shortages of medical radioisotopes that severely impact cancer diagnosis and treatments.
This includes bringing critical medical isotopes to market by early 2027, scaling the production of its modular MSF reactors, and advancing fusion research.
- With this new capital and its new facility being developed at the former Berkeley Power Station, the firm intends to run multiple next-generation compact fusion reactors at full capacity by the end of 2026.
- " Lee Lindley, who led the investment on behalf of Mercia Ventures, said: "Astral's technology has the potential to transform the manufacturing and supply of medical isotopes, which are vitally important for diagnostic and therapeutic purposes.
Astral Systems is a perfect example of the bold ideas that Mercia likes to back.
- These projects address some of the biggest concerns within both the fission and fusion power industries by ensuring a healthy supply of nuclear fuel.
Stats & Key Facts
- #Astral Systems, a deeptech company pioneering multi-state fusion (MSF) technology, has secured a £23 million first close investment led by Mercia Ventures.
- #Cate Lawrence 2 hours ago Share 1 Send email Copy link Astral Systems, a deeptech company pioneering multi-state fusion (MSF) technology, has secured a £23 million first close investment led by Mercia Ventures .
- #The raise brings the company's funding of Astral Systems to over £28 million.
- #With this new funding we can accelerate our ambition of building a profitable, impactful fusion business, and build on the momentum of the past 12 months with the backing of our investors.
Astral Fusion is developing fusion technologies for life-saving radioisotopes, clean energy, and future space exploration. Deeptech Astral Systems raises £23M to tackle the global shortages of medical radioisotopes Astral Fusion is developing fusion technologies for life-saving radioisotopes, clean energy, and future space exploration. Cate Lawrence 2 hours ago Share 1 Send email Copy link Astral Systems, a deeptech company pioneering multi-state fusion (MSF) technology, has secured a £23 million first close investment led by Mercia Ventures .
The round is supported by various investors including Tees River, Daphni, and Blast Club, alongside previous investors Speedinvest and Playfair. The raise brings the company's funding of Astral Systems to over £28 million. Astral Systems is turning breakthrough physics into a new class of commercially viable fusion technology with near-term applications.
It aims to tackle the fragile supply chain and potential global shortages of medical radioisotopes that severely impact cancer diagnosis and treatments. This includes bringing critical medical isotopes to market by early 2027, scaling the production of its modular MSF reactors, and advancing fusion research. Unlike traditional fusion ventures focused solely on long-term power generation, Astral Systems has multiple Technology Readiness Level 9 (TRL9) fusion reactors operational today.
For more details please read the original article at Tech.eu.
Continue Learning
Comments
Sign in to join the conversation